{"id":4743,"date":"2026-02-05T07:08:13","date_gmt":"2026-02-05T13:08:13","guid":{"rendered":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?p=4743"},"modified":"2026-02-09T02:35:15","modified_gmt":"2026-02-09T08:35:15","slug":"trulicity-vs-wegovy","status":"publish","type":"post","link":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/","title":{"rendered":"Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs &#8211; Diabetes vs Obesity Drugs"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Wegovy delivers approximately <\/span><b>15% body weight loss<\/b><span style=\"font-weight: 400;\"> in clinical trials-dramatically outperforming Trulicity\u2019s average weight reduction of about <\/span><b>7\u201310 lbs<\/b><span style=\"font-weight: 400;\"> (3\u20135% of body weight).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight loss results than Trulicity. This makes the choice between these injectable medications heavily dependent on whether your primary clinical need is chronic weight management or type 2 diabetes care with glycemic control.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183\"><span style=\"font-weight: 400;\">STEP 1 trial<\/span><\/a><span style=\"font-weight: 400;\"> demonstrated Wegovy\u2019s superior weight loss effects, while the <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7896253\/\"><span style=\"font-weight: 400;\">AWARD-11 trial<\/span><\/a><span style=\"font-weight: 400;\"> established Trulicity\u2019s dosing range for blood sugar control. Both carry FDA boxed warnings for thyroid C-cell tumors, including medullary thyroid carcinoma (MTC).<\/span><\/p>\n<h2>TL;DR<\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Wegovy (semaglutide) and Trulicity (dulaglutide) are both once-weekly GLP-1 receptor agonist injections, but they serve different primary purposes.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Wegovy is approved for chronic weight management<\/b><span style=\"font-weight: 400;\"> and delivers approximately 15% body weight loss in clinical trials.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Trulicity is approved for type 2 diabetes<\/b><span style=\"font-weight: 400;\"> and produces a more modest weight loss of roughly 3\u20135% of body weight.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Both medications reduce the risk of major cardiovascular events and share common gastrointestinal side effects.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Trulicity costs less versus Wegovy\u2019s list price, and Trulicity enjoys broader insurance coverage for diabetes management.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Your endocrinologist should determine the best choice based on whether your primary goal is blood sugar control or significant weight loss.<\/span><\/li>\n<\/ul>\n<h2>Trulicity vs Wegovy Mechanism + Indications<\/h2>\n<table>\n<tbody>\n<tr>\n<td><b>Feature<\/b><\/td>\n<td><b>Trulicity (Dulaglutide)<\/b><\/td>\n<td><b>Wegovy (Semaglutide)<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Primary Use<\/span><\/td>\n<td><span style=\"font-weight: 400;\">T2D + CV Benefit<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Obesity + CV\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Active Ingredient<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Dulaglutide<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Semaglutide<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Mechanism<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 Receptor Agonist<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 Receptor Agonist<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Max Dose<\/span><\/td>\n<td><span style=\"font-weight: 400;\">4.5 mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.4 mg weekly<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Dose Range<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.75\u20134.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.25\u20132.4 mg<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weight Loss<\/span><\/td>\n<td><span style=\"font-weight: 400;\">6\u201310 lbs (~3\u20135%)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~15% body weight\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">FDA Approval<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Type 2 Diabetes<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Chronic Weight Management<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Both <\/span><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/wegovy\/\"><span style=\"font-weight: 400;\">Wegovy<\/span><\/a><span style=\"font-weight: 400;\"> and <\/span><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/trulicity\/\"><span style=\"font-weight: 400;\">Trulicity<\/span><\/a><span style=\"font-weight: 400;\"> are GLP-1 medications that bind to GLP-1 receptors to stimulate insulin release in response to high blood sugar levels, slow gastric emptying, reduce appetite and enhance feelings of fullness-leading to lower calorie intake and improved blood sugar control.<\/span><\/p>\n<h2>Weight Loss Results &#8211; Wegovy 2.5x Superior<\/h2>\n<table>\n<tbody>\n<tr>\n<td><b>Duration<\/b><\/td>\n<td><b>Trulicity Loss<\/b><\/td>\n<td><b>Wegovy Loss<\/b><\/td>\n<td><b>Superiority<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">6 months<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~6 lbs<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~20 lbs\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~3.3x<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">12 months<\/span><\/td>\n<td><span style=\"font-weight: 400;\">7\u201310 lbs<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~35 lbs<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~4x<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">% Body Wt<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~3\u20135%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~15%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~3\u20135x<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">In the landmark <\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183\"><span style=\"font-weight: 400;\">STEP 1 trial<\/span><\/a><span style=\"font-weight: 400;\">, participants on semaglutide 2.4 mg achieved a mean weight loss of 14.9% of body weight over 68 weeks-compared to just 2.4% for placebo. The <\/span><a href=\"https:\/\/www.nature.com\/articles\/s41591-022-02026-4\"><span style=\"font-weight: 400;\">STEP 5 trial<\/span><\/a><span style=\"font-weight: 400;\"> confirmed sustained weight loss over a full 104 weeks.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">By contrast, Trulicity\u2019s <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7896253\/\"><span style=\"font-weight: 400;\">AWARD-11 trial<\/span><\/a><span style=\"font-weight: 400;\"> showed the highest dose (4.5 mg) produced a weight reduction of approximately 4.7 kg (~10.4 lbs) at 36 weeks-a modest but clinically meaningful secondary benefit for patients primarily managing type 2 diabetes.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">For patients whose weight loss journey is the primary goal, Wegovy is the clear clinical choice with results approaching those seen with gastric sleeve surgery.<\/span><\/p>\n<h2>A1c Reduction + CV Protection<\/h2>\n<table>\n<tbody>\n<tr>\n<td><b>Metric<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Wegovy<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">A1c Reduction<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Up to 1.8%\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Up to 1.6%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">CV Risk Reduction<\/span><\/td>\n<td><span style=\"font-weight: 400;\">12% (REWIND)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20% (SELECT)\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">CV Trial Population<\/span><\/td>\n<td><span style=\"font-weight: 400;\">T2D \u00b1 CVD<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Obesity + CVD, No T2D<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/trulicityr-dulaglutide-significantly-reduced-major\"><span style=\"font-weight: 400;\">REWIND trial<\/span><\/a><span style=\"font-weight: 400;\"> demonstrated that Trulicity reduced major adverse cardiovascular events (MACE) by 12% (HR 0.88) in adults with type 2 diabetes who had established cardiovascular disease or multiple cardiovascular risk factors-across a median follow-up of 5.4 years.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.novonordisk.com\/news-and-media\/news-and-ir-materials\/news-details.html?id=166301\"><span style=\"font-weight: 400;\">SELECT trial<\/span><\/a><span style=\"font-weight: 400;\"> showed Wegovy reduced MACE by 20% (HR 0.80) in adults with established cardiovascular disease and obesity or overweight without diabetes. In March 2024, this data led to <\/span><a href=\"https:\/\/www.prnewswire.com\/news-releases\/wegovy-receives-fda-approval-for-cardiovascular-risk-reduction-in-adults-with-known-heart-disease-and-overweight-or-obesity-302084454.html\"><span style=\"font-weight: 400;\">Wegovy\u2019s FDA-approved cardiovascular indication<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">For blood sugar control specifically, Trulicity has the longer track record in diabetes care, with A1c reductions of up to 1.8% at the 4.5 mg dose (AWARD-11). Both medications are indicated to reduce the risk of cardiovascular events, making them valuable tools for patients with multiple cardiovascular risk factors.<\/span><\/p>\n<h2>Side Effects Comparison<\/h2>\n<p><span style=\"font-weight: 400;\">Both Wegovy and Trulicity commonly cause gastrointestinal side effects. However, Wegovy causes approximately 2x greater GI intensity due to its higher obesity-targeted dosing.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trulicity may cause more intense nausea compared to Wegovy, while Trulicity is more often associated with fatigue as a side effect. Most GI symptoms resolve by week 12 in approximately 75% of patients for both medications.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Side Effect<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Wegovy<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Nausea<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~22%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~44%\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Diarrhea<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~13%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~30%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Vomiting<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~10%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~24%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">GI Total<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~35%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~82%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Fatigue<\/span><\/td>\n<td><span style=\"font-weight: 400;\">More common\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Less common<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Headache\/Dizziness<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Less common<\/span><\/td>\n<td><span style=\"font-weight: 400;\">More common\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Discontinuation Rate<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~5%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~7%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span style=\"font-weight: 400;\">Serious risks shared by both medications include:<\/span><\/h3>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Thyroid C-cell tumors: <\/b><span style=\"font-weight: 400;\">Both carry an <\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215256s024lbl.pdf\"><span style=\"font-weight: 400;\">FDA boxed warning<\/span><\/a><span style=\"font-weight: 400;\"> for an increased risk of thyroid tumors, including medullary thyroid carcinoma (MTC). They are contraindicated in patients with a personal or family history of MTC.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Pancreatitis: <\/b><span style=\"font-weight: 400;\">Risk of inflammation of the pancreas with both medications. Patients should seek immediate medical attention for severe abdominal pain.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Gallbladder problems: <\/b><span style=\"font-weight: 400;\">Rapid weight loss can increase gallstone risk with both drugs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Kidney problems: <\/b><span style=\"font-weight: 400;\">Both medications can affect kidney function, so careful monitoring is important, especially for patients with existing kidney issues.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Low blood sugar (hypoglycemia): <\/b><span style=\"font-weight: 400;\">Risk increases when used with insulin or sulfonylureas. Patients taking other diabetes medications should discuss drug interactions with their healthcare providers.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Allergic reactions: <\/b><span style=\"font-weight: 400;\">Serious allergic reactions are possible. Patients should seek immediate medical attention for symptoms such as swelling, rash, or difficulty breathing.<\/span><\/li>\n<\/ol>\n<h2>Cost Comparison 2026<\/h2>\n<p><span style=\"font-weight: 400;\">Out-of-pocket costs for both medications can vary widely depending on insurance coverage and available discount programs. At list price, Wegovy is significantly pricier than Trulicity. However, the pricing landscape shifted dramatically in late 2025, when the <\/span><a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/11\/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients\/\"><span style=\"font-weight: 400;\">White House announced negotiated prices<\/span><\/a><span style=\"font-weight: 400;\"> through TrumpRx that bring Wegovy to $350\/month and Trulicity to $389\/month for eligible patients.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Source<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Wegovy<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">List Price<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~$987\/mo<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~$1,349\/mo<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Pandameds.com<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$373.00<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$599.95<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">TrumpRx \/ Negotiated<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$389\/mo\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$350\/mo\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Medicare T2D Copay<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~$35\u2013$50<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~$50<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Self-Pay (Savings)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Varies<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$199\u2013$499\/mo<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Weight Loss Coverage<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Limited<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Switching Trulicity \u2192 Wegovy Protocol<\/h2>\n<table>\n<tbody>\n<tr>\n<td><b>Last Trulicity Dose<\/b><\/td>\n<td><b>First Wegovy Dose<\/b><\/td>\n<td><b>Timing<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">\u22641.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.25 mg\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Day 1<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">3.0\u20134.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.5 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Day 1<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Switching from Trulicity to Wegovy is common for patients who need greater weight loss effects beyond what Trulicity provides. Because both are in the same class of GLP-1 receptor agonists, no washout period is required-dulaglutide has a roughly 5-day half-life, and patients can start Wegovy on Day 1 after their last Trulicity dose.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Healthcare providers typically start with a lower dose of Wegovy (0.25 mg) and follow the standard dose-escalation schedule, with the dosage gradually increased every four weeks to minimize GI side effects.\u00a0<\/span><\/p>\n<p><b>Careful monitoring<\/b><span style=\"font-weight: 400;\"> by your healthcare provider during the switching period is essential, particularly regarding blood glucose levels and any gastrointestinal symptoms.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5536,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,37,26],"tags":[],"class_list":["post-4743","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-trulicity","category-wegovy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison<\/title>\n<meta name=\"description\" content=\"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison\" \/>\n<meta property=\"og:description\" content=\"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pandameds.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pandameds99\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T13:08:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-09T08:35:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1044\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:site\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\"},\"author\":{\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\"},\"headline\":\"Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs &#8211; Diabetes vs Obesity Drugs\",\"datePublished\":\"2026-02-05T13:08:13+00:00\",\"dateModified\":\"2026-02-09T08:35:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\"},\"wordCount\":1005,\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp\",\"articleSection\":[\"Blog\",\"Trulicity\",\"Wegovy\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\",\"name\":\"Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp\",\"datePublished\":\"2026-02-05T13:08:13+00:00\",\"dateModified\":\"2026-02-09T08:35:15+00:00\",\"description\":\"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp\",\"width\":1920,\"height\":1044,\"caption\":\"Trulicity vs Wegovy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs &#8211; Diabetes vs Obesity Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"name\":\"Pandameds.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"alternateName\":\"Pandameds\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\",\"name\":\"Pandameds.com\",\"alternateName\":\"PandaMeds\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"width\":182,\"height\":30,\"caption\":\"Pandameds.com\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Pandameds99\/\",\"https:\/\/x.com\/Pandameds99\",\"https:\/\/www.instagram.com\/_pandameds\/\",\"https:\/\/www.trustpilot.com\/review\/pandameds.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\",\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"caption\":\"Dr. Kristianne Hannemann, PharmD\"},\"description\":\"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/\"],\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison","description":"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/","og_locale":"en_US","og_type":"article","og_title":"Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison","og_description":"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.","og_url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/","og_site_name":"Pandameds.com","article_publisher":"https:\/\/www.facebook.com\/Pandameds99\/","article_published_time":"2026-02-05T13:08:13+00:00","article_modified_time":"2026-02-09T08:35:15+00:00","og_image":[{"width":1920,"height":1044,"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp","type":"image\/webp"}],"author":"Dr. Kristianne Hannemann, PharmD","twitter_card":"summary_large_image","twitter_creator":"@Pandameds99","twitter_site":"@Pandameds99","twitter_misc":{"Written by":"Dr. Kristianne Hannemann, PharmD","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#article","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/"},"author":{"name":"Dr. Kristianne Hannemann, PharmD","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a"},"headline":"Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs &#8211; Diabetes vs Obesity Drugs","datePublished":"2026-02-05T13:08:13+00:00","dateModified":"2026-02-09T08:35:15+00:00","mainEntityOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/"},"wordCount":1005,"publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp","articleSection":["Blog","Trulicity","Wegovy"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/","name":"Trulicity vs Wegovy 2026: 15% Weight Loss vs 7lb + Diabetes vs Obesity Comparison","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp","datePublished":"2026-02-05T13:08:13+00:00","dateModified":"2026-02-09T08:35:15+00:00","description":"Trulicity vs Wegovy: GLP-1 diabetes pen (7lb average loss) vs obesity injection (15% body weight). A1C control vs superior fat loss. Weekly dosing comparison, side effects (hypoglycemia vs nausea), cost analysis, clinical trial data, and switching protocol for T2D + weight management patients.","breadcrumb":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#primaryimage","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Wegovy.webp","width":1920,"height":1044,"caption":"Trulicity vs Wegovy"},{"@type":"BreadcrumbList","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-wegovy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/"},{"@type":"ListItem","position":2,"name":"Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs &#8211; Diabetes vs Obesity Drugs"}]},{"@type":"WebSite","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","name":"Pandameds.com","description":"","publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"alternateName":"Pandameds","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization","name":"Pandameds.com","alternateName":"PandaMeds","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","width":182,"height":30,"caption":"Pandameds.com"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pandameds99\/","https:\/\/x.com\/Pandameds99","https:\/\/www.instagram.com\/_pandameds\/","https:\/\/www.trustpilot.com\/review\/pandameds.com"]},{"@type":"Person","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a","name":"Dr. Kristianne Hannemann, PharmD","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","caption":"Dr. Kristianne Hannemann, PharmD"},"description":"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.","sameAs":["https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/"],"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/"}]}},"_links":{"self":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/4743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/comments?post=4743"}],"version-history":[{"count":2,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/4743\/revisions"}],"predecessor-version":[{"id":4768,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/4743\/revisions\/4768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media\/5536"}],"wp:attachment":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media?parent=4743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/categories?post=4743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/tags?post=4743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}